Chesapeake Capital Corp IL Sells 1,453 Shares of UFP Technologies, Inc. (NASDAQ:UFPT)

Chesapeake Capital Corp IL lowered its position in shares of UFP Technologies, Inc. (NASDAQ:UFPTFree Report) by 40.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,125 shares of the industrial products company’s stock after selling 1,453 shares during the period. Chesapeake Capital Corp IL’s holdings in UFP Technologies were worth $520,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in the company. Wasatch Advisors LP lifted its stake in UFP Technologies by 65.4% during the third quarter. Wasatch Advisors LP now owns 420,549 shares of the industrial products company’s stock worth $133,188,000 after purchasing an additional 166,262 shares during the last quarter. State Street Corp lifted its stake in shares of UFP Technologies by 1.4% in the 3rd quarter. State Street Corp now owns 283,460 shares of the industrial products company’s stock valued at $89,772,000 after acquiring an additional 4,007 shares during the last quarter. Congress Asset Management Co. lifted its stake in shares of UFP Technologies by 14.2% in the 4th quarter. Congress Asset Management Co. now owns 281,325 shares of the industrial products company’s stock valued at $68,787,000 after acquiring an additional 35,022 shares during the last quarter. Geode Capital Management LLC lifted its stake in shares of UFP Technologies by 2.0% in the 3rd quarter. Geode Capital Management LLC now owns 172,996 shares of the industrial products company’s stock valued at $54,799,000 after acquiring an additional 3,333 shares during the last quarter. Finally, Boston Trust Walden Corp bought a new stake in shares of UFP Technologies in the 4th quarter valued at about $26,395,000. Institutional investors own 87.28% of the company’s stock.

Insider Activity at UFP Technologies

In related news, Director Daniel C. Croteau sold 6,846 shares of the business’s stock in a transaction dated Thursday, February 27th. The stock was sold at an average price of $228.41, for a total transaction of $1,563,694.86. Following the transaction, the director now owns 1,785 shares in the company, valued at $407,711.85. The trade was a 79.32 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 6.17% of the stock is owned by company insiders.

Analysts Set New Price Targets

Separately, StockNews.com lowered UFP Technologies from a “hold” rating to a “sell” rating in a research note on Thursday, January 23rd.

View Our Latest Research Report on UFPT

UFP Technologies Trading Down 4.3 %

NASDAQ UFPT opened at $206.98 on Wednesday. UFP Technologies, Inc. has a 1-year low of $193.70 and a 1-year high of $366.41. The firm has a market cap of $1.59 billion, a PE ratio of 29.53 and a beta of 1.15. The company has a current ratio of 2.57, a quick ratio of 1.43 and a debt-to-equity ratio of 0.64. The stock has a 50-day moving average of $249.27 and a 200-day moving average of $279.87.

UFP Technologies (NASDAQ:UFPTGet Free Report) last announced its quarterly earnings results on Tuesday, February 25th. The industrial products company reported $2.46 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.01 by $0.45. UFP Technologies had a return on equity of 18.92% and a net margin of 11.74%. The company had revenue of $144.07 million for the quarter, compared to the consensus estimate of $141.67 million.

UFP Technologies Profile

(Free Report)

UFP Technologies, Inc designs and manufactures solutions for medical devices, sterile packaging, and other highly engineered custom products. The company offers protective drapes for robotic surgery, single patient use surfaces, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic implants, biopharma drug manufacturing, and coils for catheters; and molded components for applications in acoustic insulation, interior trim, load floors, sunshades, SUV cargo cover handles, driveshaft damping, engine and manifold covers, quarter panels, and wheel liners.

Featured Articles

Institutional Ownership by Quarter for UFP Technologies (NASDAQ:UFPT)

Receive News & Ratings for UFP Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UFP Technologies and related companies with MarketBeat.com's FREE daily email newsletter.